Imgn investors hub
Witryna1 mar 2024 · The Investor Relations website contains information about ImmunoGen, Inc.'s business for stockholders, potential investors, and financial analysts. Witryna11 kwi 2024 · About IMGN. ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's …
Imgn investors hub
Did you know?
Witryna15 lut 2024 · SGO/SORAYA Investor Event. Listen to webcast. Supporting Materials. View Presentation 1.1 MB. Mar 9, 2024 12:50 PM EST Cowen 42nd Annual Health Care Conference - Ovarian Cancer Panel. Listen to webcast. Feb 25, 2024 8:00 AM EST ImmunoGen Full Year 2024 Operating Results Conference Call. Listen to webcast ... WitrynaBusiness Wire. ImmunoGen, Inc., a commercial-stage biotechnology company, focuses on developing and commercializing the antibody-drug conjugates (ADCs) for cancer …
Witryna29 mar 2024 · IMGN has an average analyst rating of buy and is -69.05% away from its mean target price of $12.44 per share. Its trailing 12 month earnings per share (EPS) is $-0.77 ... Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an … Witryna364,900. 14.822%. $15,745. Back to IMGN Overview. Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. …
Witryna8 kwi 2024 · ImmunoGen, Inc. Message board - Online Community of active, educated investors researching and discussing ImmunoGen, Inc. Stocks. Home Recent Posts … WitrynaBusiness Wire. ImmunoGen, Inc., a commercial-stage biotechnology company, focuses on developing and commercializing the antibody-drug conjugates (ADCs) for cancer patients. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), for the treatment of platinum-resistant ovarian …
Witryna10 kwi 2024 · View ImmunoGen, Inc IMGN investment & stock information. Get the latest ImmunoGen, Inc IMGN detailed stock quotes, stock data, Real-Time ECN, …
Witryna29 mar 2024 · The table shows changes in IMGN in the past 3 months by investors with public portfolios. Investor activity updates every 24 hours. IMGN Investors Also Bought. Name. Average Holding Size. Last 7D Change. Last 30D Change. Market Cap. Sector. 3M Behavior. Follow. GE. General Electric. 6.04% +0.03% +1.95%. imusic apk downloadWitryna15 gru 2024 · Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged through the end of November. Among them, Facebook and Microsoft ranked among the top 3 picks ... lithonia ez1 led driverWitrynaSearch Investment Rounds; Search Exit Events; Search Investment Funds ... lithonia f150ml m4WitrynaOver the past twelve months, IMGN has reported earnings growth of 184.54%, putting it ahead of 91.47% of US stocks in our set. Revenue growth over the past 12 months … lithonia extl sp1100lWitryna16 gru 2015 · Interesting IMGN Put And Call Options For July 2024 Monday, November 21, 11:03 AM. Notable Tuesday Option Activity: BC, IMGN, DDOG Tuesday, … imusic anmeldenWitrynaImmunoGen Inc. (NASDAQ:IMGN) has a beta value of 0.93 and has seen 2.94 million shares traded in the last trading session. The company, currently valued at $944.08M, … lithonia f70sl 120 m6WitrynaDiscover historical prices for IMGN stock on Yahoo Finance. View daily, weekly or monthly format back to when ImmunoGen, Inc. stock was issued. imushin dofus